February 25, 2022
Tumor tissue modified viral-HPV DNA test predicts HPV-driven oropharynx cancer recurrence
A blood test to detect circulating tumor DNA accurately predicted recurrence of HPV-driven oropharyngeal cancer after treatment, according to research presented at Multidisciplinary Head and Neck Cancers Symposium.